Entity family
Clinical therapies and care approaches used to manage a condition. Examples include immunotherapy, radiotherapy, rehabilitation.
This treatment is selected. Its supporting articles are shown below.
…ch as autologous stem cell transplantation (HSCT) are used (3). Chimeric antigen receptor (CAR) T cell therapy is a promising alternative option (4-8). Here we report an upda…
…Background Chimeric antigen receptor (CAR) T cell therapy has shown remarkable success in hematologic malignancies but fa…
…Background Chimeric antigen receptor (CAR) T cell therapy has demonstrated remarkable clinical efficacy in haematological…
…Background Chimeric Antigen Receptor (CAR) T cell therapy is an adoptive cell therapy in which cells are genetically modi…
…es with enhanced tumor progression and poor prognosis. However, chimeric antigen receptor (CAR) T cell therapy—an effective strategy in hematologic malignancies—has emerged a…
…ently associated with bone metastases and poor prognosis. While chimeric antigen receptor (CAR) T cell therapy holds promise for mCRPC, clinical translation has been limited …
…Background Chimeric antigen receptor (CAR) T cell therapy has revolutionized hematological cancer treatment but faces sig…
…Background Chimeric antigen receptor (CAR) T cell therapy has revolutionized the treatment of blood cancers, but its effi…
…Background Chimeric antigen receptor (CAR) T cell therapy has shown promise in relapsed/refractory multiple myeloma (r/rM…
…Background Chimeric antigen receptor (CAR) T cell therapy has revolutionized treatment for hematologic malignancies, but …
… The effects of ancestry on emerging therapy approaches such as chimeric antigen receptor (CAR) T cell therapy and proteolysis-targeting chimeras (PROTACs) therapy are also b…
…d cancers are often refractory to existing therapies, including Chimeric Antigen Receptor (CAR) T cell therapy. While CAR T cells have revolutionized the treatment of hematol…